CymaBay Therapeutics
Developing therapies for liver and other chronic diseases with high unmet medical need. Learn more
Launch date
Employees
Market cap
€3.4b
Enterprise valuation
€3.1b (Public information from Mar 2024)
Share price
$32.48 CBAY
Hayward California (HQ)
Authorizing premium user...